CUSHING'S SYNDROME IN PREGNANCY—TREATMENT WITH METYRAPONE
The DOI matches its Crossref record.
Abstract
SUMMARY: A 23‐year‐old female presented with severe Cushing's syndrome in the 23rd week of pregnancy. Investigations showed plasma cortisol 770 nmol/l (08.00 h) and 850 nmol/l (23.00 h); plasma ACTH was 10 ng/l (08.00 h) and 27 ng/l (23.00 h); urinary free cortisol excretion was 2460 nmol/24 h. Dexamethasone 2 mg 6‐hourly for 48 h suppressed the 08.00 h plasma cortisol only to 680 nmol/l. Abdominal C.T. scan showed a right adrenal adenoma. The patient was treated with metyrapone and a good clinical improvement ensued. Plasma cortisol was reduced to 300–500 nmol/l. Despite ultrasonographic evidence of normal fetal growth, urinary oestriol excretion was markedly deficient. Prior to the spontaneous onset of labour, there was a marked rise in plasma cortisol despite continuous metyrapone treatment. A normal female infant was born at 37 weeks' gestation. The maternal adrenal adenoma was subsequently removed. The deficiency of oestriol synthesis during the pregnancy may be explained by metyrapone‐induced inhibition of C19‐hydroxylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment
Lindsay, J. R., & Nieman, L. K. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0025 · Cited by 449
“The efficacy of the 8 mg dexamethasone suppression test for the differential diagnosis of ectopic ACTH secretion in pregnancy is unknown due to the limited number of reported cases (161, 163, 171, 178, 179, 189-191).”
BackgroundCushing’s Syndrome during Pregnancy: Personal Experience and Review of the Literature
Lindsay, J. R., Jonklaas, J., Oldfield, E. H., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2361 · Cited by 343
Verhelst, J. A., Trainer, P. J., Howlett, T. A., Perry, L., Rees, L. H., Grossman, A. B., Wass, J. A. H., & Sesser, G. M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03517.x · Cited by 308
“The effects of metyrapone in the ectopic-ACTH syndrome and adrenocortical tumours confirms earlier reports by documenting the excellent and fast control that can be obtained (Orth & Liddle, 1971; Orth, 1972; Beardwell et al., 1981; Gormley et al., 1982; Thoren ef ul., 1985).”
ResultMedical Therapy for Cushing’s Syndrome in the Twenty-first Century
Tritos, N. A., & Biller, B. M. K. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.01.006 · Cited by 24
Metadata
- Authors
- GORMLEY, M. J. J., HADDEN, D. R., KENNEDY, T. L., MONTGOMERY, D. A. D., MURNAGHAN, G. A., & SHERIDAN, B.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1982-03
- Volume
- 16
- Issue
- 3
- Pages
- 283-293
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1989823950
- Cited by
- 99
- References
- 0
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CUSHING'S SYNDROME IN PREGNANCY—TREATMENT WITH METYRAPONE. https://app.cochat.ai/papers/10.1111/j.1365-2265.1982.tb00718.x
- The paper
- GORMLEY, M. J. J., HADDEN, D. R., KENNEDY, T. L., MONTGOMERY, D. A. D., MURNAGHAN, G. A., & SHERIDAN, B. (1982). CUSHING'S SYNDROME IN PREGNANCY—TREATMENT WITH METYRAPONE. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1982.tb00718.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.